Introduction
============

Trisomy 16 is recognized as the most common type of trisomy in first-trimester spontaneous abortions, occurring in 1% of all clinically recognized pregnancies, while being rarer in the second and third trimesters ([@b1-etm-0-0-7695]--[@b3-etm-0-0-7695]). Early lethality and incompatibility with life have been described as its major outcomes ([@b1-etm-0-0-7695]). Trisomy 16 may be classified into three major types: Full trisomy, mosaics and partial trisomy of 16p or 16q. Since Schmickel ([@b4-etm-0-0-7695]) reported the first case of 16q trisomy as identified using a chromosome banding technique in 1975, \>30 cases of partial trisomy 16q have been described. The common clinical features of trisomy 16q include low birthweight, hypotonia, failure to thrive, psychomotor retardation, periorbital edema, high prominent forehead, microcephaly, low-set ears, flat nasal bridge, small and down-slanting palpebral fissures, micrognathia, hypertelorism, long philtrum and posterior cleft palate ([@b3-etm-0-0-7695]). In the literature, few cases of 16q trisomy among liveborn infants have been reported. The unbalanced segregation of a parental balanced translocation frequently leads to partial trisomy 16, which is common in newborns and is associated with a wide range of clinical congenital abnormalities ([@b5-etm-0-0-7695]).

Pure terminal deletions of 2p are rare in a clinical context. To date, \~30 such patients have been reported, who share the following common clinical features: Early-onset obesity/overweight associated with intellectual disabilities and behavioral difficulties ([@b6-etm-0-0-7695]--[@b8-etm-0-0-7695]).

The present case study reports on a male newborn with multi-organ malformations exhibiting partial trisomy 16q21→qter and monosomy 2p25.3→pter. The proband exhibited the clinical manifestations of congenital muscular torticollis and congenital laryngomalacia, which have not been reported previously in either trisomy 16q or monosomy 2p. The clinical features of cases reported in the published literature were also described.

Case report
===========

The proband was admitted to the neonatal department at The First Hospital of Jilin University (Changchun, Jilin) due to wet lung and small stature for his gestational age directly after birth in March 2017. The patient was born at 40 weeks 3 days of gestation, with a body weight of 2,350 g, body height of 46 cm and Apgar scores of 6 at 1 min and 8 at 5 min. The infant was the first child of the non-consanguineous and healthy couple: A 32-year-old father and a 28-year-old mother, who had taken a tocolytic agent due to suspected risk of spontaneous abortion in the first trimester. Physical examination indicated that the proband had small anterior fontanelles, prominent forehead, low hairline, telecanthus, flat nasal bridge, choanal atresia, clinodactyly of the fifth fingers, small penis and right cryptorchidism. Brain magnetic resonance imaging indicated no obvious brain abnormalities, but regular follow-up to dynamically observe the proband\'s neurological condition remained necessary. At the age of 2 days, abnormal findings from chest X-rays revealed pneumonia in the patient, with the ultrasonic cardiogram exhibiting patent ductus arteriosus. Given an intolerance for normal feeding of the patient, feeding was accomplished via a nasogastric tube. The patient also presented with poor psychomotor development. Considering that the subject failed a hearing screening test and was positive for cytomegalovirus pp65 antigen, ganciclovir therapy was performed. Subsequently, congenital muscular torticollis (at 19 days) and congenital laryngomalacia (at 24 days) were diagnosed. Finally, the proband developed stable vital signs and was discharged at the age of one month old. At 19 months after the proband\'s birth, a follow-up was performed, during which the presence of low-set ears, torticollis, hypotonia and an inability to walk were noted, and laryngeal wheezing during sleep was reported. The parents refused surgical treatments for the right cryptorchidism and laryngomalacia. The protocol of the present study was approved by the Ethics Committee of the First Hospital of Jilin University (Changchun, China) and written informed consent was obtained from the parents of the patient.

From the proband, 5 ml of peripheral blood was collected using a standard vacuum extraction blood-collecting system containing EDTA and heparin. Genomic DNA was isolated from whole blood using a QIAamp DNA Mini kit (Qiagen GmbH) in accordance with the manufacturer\'s protocol.

Chromosome microarray (CMA) was performed using Affymetrix CytoScan HD arrays, in accordance with the manufacturer\'s protocol. The procedure included genomic DNA extraction, digestion and ligation, PCR amplification, PCR product purification, quantification and fragmentation, labeling, array hybridization, washing and scanning. The array was designed specifically for cytogenetic research, including \~1,950,000 copy number variation markers and 750,000 single-nucleotide polymorphism markers. Data were analyzed using Affymetrix Chromosome Analysis Suite v3.3 Software. Thresholds for genome-wide screening were set at ≥100 kb for gains and ≥50 kb for losses. The detected copy number gains or losses were systematically evaluated for clinical significance by comparing them with values reported in the scientific literature and the following databases: i) Database of Genomic Variants (<http://projects.tcag.ca/variation/>), ii) DECIPHER (<http://decipher.sanger.ac.uk/>), iii) ISCA (<https://www.iscaconsortium.org/>), iv) ECARUCA (<http://www.ecaruca.net>), v) Online Mendelian Inheritance in Man (OMIM; <http://www.ncbi.nlm.nih.gov/omim>) and vi) Clinical Genome Resource (<https://www.clinicalgenome.org/>; ([@b9-etm-0-0-7695]). The CMA results for the proband revealed a 1.4 Mb deletion of 2p25.3 (12,770-1,393,107; [Fig. 1A](#f1-etm-0-0-7695){ref-type="fig"}) and a 30.2 Mb duplication of 16q21q24.3 (59,939,853-90,155,062; [Fig. 1B](#f1-etm-0-0-7695){ref-type="fig"}).

To further identify the chromosomal anomalies, blood from the proband and the proband\'s parents was obtained for karyotyping after obtaining written informed consent, in accordance with conventional G-banding techniques. The ISCN 2013 nomenclature was used to describe the karyotype ([@b10-etm-0-0-7695]). The proband\'s karyotype was 46,XY,der(2)t(2;16)(p25;q21)pat ([Fig. 2A](#f2-etm-0-0-7695){ref-type="fig"}). The proband\'s father\'s karyotype was 46,XY,t(2;16)(p25;q21) ([Fig. 2B](#f2-etm-0-0-7695){ref-type="fig"}) and the proband\'s mother\'s karyotype was 46,XX. Thus, the proband was trisomic for 16q21→qter due to unbalanced segregation of a paternally inherited balanced translocation. According to the follow-up, the patient remained alive and stable although he did not accept any further surgical treatments.

Discussion
==========

The present study reports on a male infant with an unbalanced der(2)t(2;16)(p25;q21) chromosome resulting in a 2p25.3 deletion and 16q24.3 duplication, presenting with psychomotor retardation, small anterior fontanelles, prominent forehead, low hairline, telecanthus, flat nasal bridge, choanal atresia, finger and genital deformities and multiple other malformations.

Trisomy 16q21→qter is a rare chromosomal abnormality among the different types of trisomy 16q. Brisset *et al* ([@b1-etm-0-0-7695]) established a series of phenotype-genotype correlations for trisomy16q: High/prominent forehead, bitemporal narrowing, periorbital edema in the neonatal period; severe mental retardation; vertebral, genital and anal abnormalities associated with 16q24; distal joint contractures and camptodactyly with 16q23; cleft palate and renal anomalies with 16q22; beaked nose and gall bladder agenesis with 16q21; gut malrotation, and lung and liver anomalies with 16q13; and behavioral abnormalities with band 16q11-q13. Barber *et al* ([@b11-etm-0-0-7695]) concluded that duplications of proximal 16q were not associated with dysmorphic features, but were linked to speech delay, learning difficulties and behavioral problems. Laus *et al* ([@b5-etm-0-0-7695]) suggested that the involved region ranging from 16q11 to 16q22 was necessary for the characteristic phenotypes of trisomy 16q.

To establish phenotype-karyotype correlations for trisomy16q21→qter, the present study mainly compared the clinical features of the present case with those from the literature on partial trisomy 16q21→qter cases, as reviewed in [Table I](#tI-etm-0-0-7695){ref-type="table"} ([@b3-etm-0-0-7695],[@b12-etm-0-0-7695]--[@b16-etm-0-0-7695]). The rates of the different clinical characteristics are as follows: Psychomotor retardation (7/7), prominent forehead (6/7), hypotonia (6/7), low-set ears (6/7), respiratory distress (5/7), urogenital anomalies (5/7), flat nasal bridge (5/7), hypertelorism (4/7), weak sucking (4/7), clinodactyly of the fifth fingers (3/7) and small anterior fontanelles (2/7). To the best of our knowledge, the present study was the first to report on congenital muscular torticollis and congenital laryngomalacia in a case of partial trisomy 16q21→qter. It is generally accepted that unbalanced segregation of a parental balanced translocation usually leads to chromosome partial trisomy and monosomy ([@b16-etm-0-0-7695]). All cases of trisomy 16q21→qter in the reviewed literature were derived from a balanced translocation of parental origin, involving monosomy of the other chromosomes (2p25.3, 4q35.2, 9p24, 10q26.3, 15p13, 18p11.2 and 22p12) at the same time. In the present case, the proband\'s karyotype was 46,XY,der(2)t(2;16)(p25;q21)pat. The proband\'s mother had a normal karyotype, while the proband\'s father\'s karyotype was 46,XY,t(2;16)(p25;q21). The proband had thus clearly inherited a paternal unbalanced translocation between chromosomes 2 and 16. It is difficult to distinguish whether the clinical phenotypes are associated with trisomy 16q and monosomy 2p separately or are a consequence of the genome rearrangements. The major limitation of the present study is that published studies on partial trisomy 16q21→qter are limited, most of which attempt to establish the phenotype- karyotype correlation through the clinical manifestations. Part of the characteristics of the present case are different from those of cases reported in the previous literature, while partial phenotypes overlap with them, which enhances the current knowledge on the phenotype-karyotype correlation to a certain extent. Furthermore, as presented in [Table I](#tI-etm-0-0-7695){ref-type="table"}, poor postnatal survival has been reported, ranging from 18 days to 7 years. Although it is impossible to make an accurate prediction regarding the proband\'s survival, it is difficult to be optimistic about his longevity.

The selection of plausible candidate genes exhibiting a 'dose effect' may partly explain the clinically observed phenotypes. The 2p25.3 region involved in the present case contains the genes family with sequence similarity 110 member C (*FAM110C*), SH3 and SYLF domain containing 1(*SH3YL1*), acid phosphatase 1 (*ACP1*), FAM150B, transmembrane protein 18 (*TMEM18*) and syntrophin gamma 2(*SNTG2*). Doco-Fenzy *et al* ([@b7-etm-0-0-7695]) reported on five patients with a 2p25 deletion presenting with early-onset obesity, hyperphagia, intellectual deficiency and behavioral difficulties. They speculated that the *ACP1* and *TMEM18* genes may be involved in early-onset obesity. Heterozygous loss of the *SNTG2* gene has been reported to be associated with intellectual deficiency and behavioral difficulties. Zou *et al* ([@b17-etm-0-0-7695]) reported on a 7-year-old female patient with a *de novo* unbalanced der(2)t(2;16)(p25.3;q24.3) chromosome resulting in 2p25.3 deletion and 16q24.3 duplication. However, the distinct trisomy 16q causes various clinical manifestations, which explains that monosomy 2p may have mild effects when associated with trisomy 16q. However, the haploinsufficiency of genes in the region of 2p25.3 has yet to be evaluated.

The genes in the region of 16q21-16q24.3 and the associated diseases are summarized in [Table II](#tII-etm-0-0-7695){ref-type="table"}. The region contains \>250 genes including 61 morbidity-associated genes. The gene chromatin licensing and DNA replication factor 1(*CDT1*), located at 16q24.3, which is required for DNA replication at multiple stages of development and mitosis, is expressed only in the G1 and S phases ([@b18-etm-0-0-7695]). The homozygous or compound heterozygous mutation of the gene *CDT1* has been indicated to be associated with Meier-Gorlin syndrome 4. Patients with this syndrome usually have short stature, distinctive facial features, low-set/rotated ears, micrognathia, full lips, a narrow nose with a high nasal bridge, patellar aplasia/hypoplasia and abnormalities in sexual development. Small testes and cryptorchidism are also involved in this condition, along with difficulty in feeding and breathing problems ([@b19-etm-0-0-7695]). Ankyrin repeat domain 11(*ANKRD11*), located in 16q24.3, is a member of a family of ankyrin repeat-containing cofactors that interacts with p160 nuclear receptor coactivators and inhibits ligand-dependent transcriptional activation ([@b20-etm-0-0-7695]). Heterozygous mutation in the *ANKRD11* gene has been reported to lead to KBG syndrome, characterized by short stature, global developmental delay, intellectual disability, distinctive craniofacial features, seizures, hypertelorism and skeletal abnormality (brachydactyly or clinodactyly) ([@b21-etm-0-0-7695],[@b22-etm-0-0-7695]). However, the triplosensitivity of these genes caused by partial trisomy 16q has not been clearly described.

In conclusion, the present case study reports on a newborn suffering from multiple organ malformations, with 2p25.3 deletion and 16q21q24.3 duplication. Concomitant partial monosomy 2p and partial trisomy 16q is unusual in a clinical context. The present results not only underline the importance of trisomy 16q21→qter, but also uncover certain unprecedented clinical features, which expand on the current knowledge of the clinical phenotypes of trisomy 16q21→qter syndrome. The limited number of relevant previous studies put a restriction on the clear delineation of the phenotype-karyotype correlation of trisomy 16q21→qter. Considering the observed clinical manifestations, the *SNTG2, CDT1* and *ANKRD11* genes are plausible candidates contributing to the proband\'s phenotype. As more and more clinical and molecular cytogenetic evaluations of cases with partial trisomy 16q emerge, it is anticipated that more accurate information on genotype-phenotype correlations will be established. Taking all of the information obtained into consideration, pre-implantation genetic diagnosis and prenatal diagnosis would be the most suitable choice if the proband\'s parents intend to conceive again.

Not applicable.

Funding
=======

The present study was supported by the Special Funds for Projects of Independent Innovation and New and Hi-tech Industry Development of Jilin Province (grant no. 2017C025).

Availability of data and materials
==================================

The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.

Authors\' contributions
=======================

FY obtained the clinical information, collected data from the literature and wrote the manuscript. YJ and YP critically reviewed the manuscript. LeL and LiL performed the cytogenetic study and CMA analysis on the proband and the proband\'s parents. RL acquired funding and designed the study. RW conceived and designed the study, and performed the final review and editing of the manuscript. All authors have read and approved the final manuscript.

Ethics approval and consent to participate
==========================================

This study was approved by the Medical Ethics Committee of the First Hospital of Jilin University (Changchun, China). The parents of the patient provided written informed consent for their child to participate in this study, and they also consented to participate themselves.

Patient consent for publication
===============================

The present case report was published with the informed consent of the patient\'s parents, whose anonymities were preserved.

Competing interests
===================

The authors declare that they have no competing interests.
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###### 

Clinical features of patients with partial trisomy 16q21→qter.

  Phenotype/presentation              Balestrazzi *et al*, 1979 ([@b12-etm-0-0-7695])   Garau *et al*, 1980 ([@b13-etm-0-0-7695])   Lessick *et al*, 1989 ([@b14-etm-0-0-7695])   Maher *et al*, 1991 ([@b3-etm-0-0-7695])   De Carvalho *et al*, 2010 ([@b15-etm-0-0-7695])   Mishra *et al*, 2018 ([@b16-etm-0-0-7695])   Present case
  ----------------------------------- ------------------------------------------------- ------------------------------------------- --------------------------------------------- ------------------------------------------ ------------------------------------------------- -------------------------------------------- ---------------------------------------------------------------
  Parental translocation              t(16;22)                                          t(16;18)                                    t(9;16)                                       t(10;16)                                   t(4;16)                                           t(15;16)                                     t(2;16)
                                      (q21;p12) mat                                     (q21;p11.2) pat                             (p24;q21)mat                                  (q26.3;q21)pat                             (q35.2;q21)mat                                    (p13;q21) mat                                (p25;q21)pat
  Sex/gestational age                 M/40 w                                            F/at term                                   F/at term                                     M/32 w                                     F/41 w                                            M/33 w                                       M/40+3 d
  Birth weight (g)                    2,600                                             2,470                                       2,325                                         IGR(\<3rd centile)                         2,400                                             1,230                                        2,350
  Birth head circumference (cm)       N.R.                                              N.R.                                        32.5                                          29                                         35                                                28                                           N.R.
  Body length (cm)                    N.R.                                              40                                          46                                            42                                         48                                                42                                           46
  Psychomotor retardation             \+                                                \+                                          \+                                            \+                                         \+                                                \+                                           \+
  Hypotonia                           \+                                                \+                                          \+                                            N.R.                                       \+                                                \+                                           \+
  High/prominent forehead             \+                                                \+                                          \+                                            \+                                         \+                                                N.R.                                         \+
  Small anterior fontanelles          \+                                                \+                                          N.R.                                          N.R.                                       \+                                                N.R.                                         \+
  Small palpebral fissures            N.R.                                              N.R.                                        \+                                            N.R.                                       \+                                                \+                                           N.R.
  Epicanthus                          \+                                                \+                                          \+                                            N.R.                                       \+                                                N.R.                                         N.R.
  Hypertelorism                       \+                                                −                                           N.R.                                          N.R.                                       \+                                                N.R.                                         \+
  Strabismus                          \+                                                \+                                          \+                                            N.R.                                       −                                                 N.R.                                         N.R.
  Broad flat nasal bridge             \+                                                N.R.                                        −                                             \+                                         \+                                                N.R.                                         \+
  Long philtrum                       \+                                                \+                                          N.R.                                          \+                                         \+                                                N.R.                                         N.R.
  Thin upper lip                      \+                                                N.R.                                        \+                                            N.R.                                       \+                                                N.R.                                         N.R.
  Micrognathia                        \+                                                N.R.                                        \+                                            \+                                         \+                                                N.R.                                         N.R.
  Dysplastic/low-set ears             \+                                                N.R.                                        \+                                            \+                                         \+                                                \+                                           \+
  Abnormal palmar creases             \+                                                \+                                          \+                                            \+                                         \+                                                N.R.                                         N.R.
  Abnormalities in palate             \+                                                N.R.                                        High palate                                   N.R.                                       High palate                                       Cleft palate                                 High palate
  Disease                             −                                                 −                                           −                                             Congenital heart disease                   Congenital heart disease                          Congenital heart disease                     Congenital muscular torticollis and congenital laryngomalacia
  Urogenital anomalies                \+                                                \+                                          −                                             \+                                         \+                                                N.R.                                         \+
  Weaksucking                         \+                                                \+                                          N.R.                                          N.R.                                       \+                                                N.R.                                         \+
  Clinodactyly of the fifth fingers   N.R.                                              N.R.                                        \+                                            N.R.                                       \+                                                N.R.                                         \+
  Respiratory distress                \+                                                \+                                          \+                                            N.R.                                       \+                                                N.R.                                         \+
  Survival time                       3 y6 m                                            22 d                                        6 m                                           18 d                                       7 y                                               10 m                                         19 m^[a](#tfn1-etm-0-0-7695){ref-type="table-fn"}^

Proband is in a stable state and alive. M, male; F, female; +, feature present; -, feature absent; N.R., not reported; m, months; d, days; y, years.

###### 

Genes in the region of 16q21-16q24.3 and the associated diseases.

  Gene       Location        OMIM     Description                                                        Disease
  ---------- --------------- -------- ------------------------------------------------------------------ ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  BEAN1      16q21           612051   Brain expressed associated with NEDD4 1                            Spinocerebellar ataxia 31
  TK2        16q21           188250   Thymidine kinase 2                                                 Mitochondrial DNA depletion syndrome 2 (myopathic type); progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 3
  CBFB       16q22.1         121360   Core-binding factor subunit beta                                   Leukemia, Acute Myeloid; AML
  HSF4       16q22.1         602438   Heat shock transcription factor 4                                  Cataract 5, multiple types
  NOL3       16q22.1         605235   Nucleolar protein 3                                                Myoclonus, familial cortical
  HSD11B2    16q22.1         614232   Hydroxysteroid 11-beta dehydrogenase 2                             Apparent mineralocorticoid excess
  CTCF       16q22.1         604167   CCCTC-binding factor                                               Mental retardation, autosomal dominant 21
  ACD        16q22.1         609377   ACD, shelterin complex subunit and telomerase recruitment factor   Dyskeratosis Congenita, Autosomal Dominant 6; DKCA6
  LCAT       16q22.1         606967   Lecithin-cholesterol acyltransferase                               Fish-eye disease; Norum disease
  AGRP       16q22.1         602311   Agouti-related neuropeptide                                        Obesity
  CDH3       16q22.1         114021   Cadherin 3                                                         Ectodermal dysplasia, ectrodactyly and macular dystrophy; hypotrichosis, congenital, with juvenile macular dystrophy
  PRMT7      16q22.1         610087   Proteinargininemethyltransferase 7                                 Short stature, brachydactyly, intellectual developmental disability and seizures
  CDH1       16q22.1         192090   Cadherin 1                                                         Breast cancer; Blepharocheilodontic syndrome 1; Gastric Cancer, Hereditary Diffuse; HDGC; Ovarian Cancer; Prostate cancer; Endometrial Cancer
  COG8       16q22.1         606979   Component of oligomericgolgi complex 8                             Congenital disorder of glycosylation, type IIh
  COG4       16q22.1         606976   Component of oligomericgolgi complex 4                             Congenital disorder of glycosylation, type IIj
  AARS       16q22.1         601065   Alanyl-tRNAsynthetase                                              Charcot-Marie-tooth disease, axonal, type 2N; epileptic encephalopathy, early infantile, 29
  NQO1       16q22.1         125860   NAD(P)H quinone dehydrogenase 1                                    Nad(P)H Dehydrogenase, Quinone 1; NQO1
  VAC14      16q22.1-q22.2   604632   Vac14, PIKFYVE complex component                                   Striatonigral degeneration, childhood-onset
  HYDIN      16q22.2         610812   HYDIN, axonemal central pair apparatus protein                     Ciliary dyskinesia, primary, 5
  DHODH      16q22.2         126064   Dihydroorotate dehydrogenase (quinone)                             Miller syndrome
  TAT        16q22.2         613018   Tyrosine aminotransferase                                          Tyrosinemia, type II
  HP         16q22.2         140100   Haptoglobin                                                        Anhaptoglobinemia
  ZFHX3      16q22.2-q22.3   104155   Zinc finger homeobox 3                                             Prostate cancer
  RFWD3      16q23.1         614151   Ring finger and WD repeat domain 3                                 Fanconi anemia; complementationgroup W
  FA2H       16q23.1         611026   Fatty acid 2-hydroxylase                                           Spastic paraplegia 35; autosomal recessive
  CHST6      16q23.1         605294   Carbohydrate sulfotransferase 6                                    Macular corneal dystrophy
  TMEM231    16q23.1         614949   Transmembrane protein 231                                          Joubert syndrome 20; Meckel syndrome 11
  KARS       16q23.1         601421   Lysyl-tRNAsynthetase                                               Charcot-Marie-Tooth disease; recessive intermediate; B; deafness, autosomal recessive 89
  ADAMTS18   16q23.1         607512   ADAM metallopeptidase with thrombospondin type 1 motif 18          Microcornea; myopic chorioretinal atrophy; telecanthus
  WWOX       16q23.1-q23.2   605131   WW domain containing oxidoreductase                                Esophageal cancer; spinocerebellar ataxia, autosomal recessive 12; epileptic encephalopathy, early infantile, 28
  MAF        16q23.2         177075   MAF bZIP transcription factor types                                Ayme-Gripp syndrome; cataract 21, multiple
  GCSH       16q23.2         238330   Glycine cleavage system protein H                                  Glycine encephalopathy
  BCMO1      16q23.2         605748   Beta-carotene oxygenase 1                                          Hypercarotenemia and vitamin A deficiency, autosomal dominant
  GAN        16q23.2         605379   Gigaxonin                                                          Giant axonal neuropathy-1
  PLCG2      16q24.1         600220   Phospholipase C gamma 2                                            Familial cold autoinflammatory syndrome 3; autoinflammation, antibody deficiency and immune dysregulation syndrome
  MLYCD      16q23.3         606761   Malonyl-CoA decarboxylase                                          Malonyl-CoA decarboxylase deficiency
  SLC38A8    16q23.3         615585   Solute carrier family 38 member 8                                  Foveal hypoplasia 2, with or without optic nerve misrouting and/or anterior segment dysgenesis
  DNAAF1     16q24.1         613190   Dynein axonemal assembly factor 1                                  Ciliary dyskinesia, primary, 13
  RF8        16q24.1         601565   Interferon regulatory factor 8                                     Immunodeficiency 32A, mycobacteriosis, autosomal dominant; immunodeficiency 32B, monocyte and dendritic cell deficiency, autosomal recessive
  FOXF1      16q24.1         601089   Forkhead box F1                                                    Alveolar capillary dysplasia with misalignment of pulmonary veins
  FOXC2      16q24.1         602402   Forkhead box C2                                                    Lymphedema-distichiasis syndrome
  FBXO31     16q24.2         609102   F-box protein 31                                                   Mental retardation, autosomal recessive 45
  JPH3       16q24.2         605268   Junctophilin 3                                                     Huntington disease-like 2
  CA5A       16q24.2         114761   Carbonic anhydrase 5A                                              Hyperammonemia due to carbonicanhydrase VA deficiency
  ZNF469     16q24.2         612078   Zinc finger protein 469                                            Brittle cornea syndrome 1
  CDT1       16q24.3         605525   Chromatin licensing and DNA replication factor 1                   Meier-Gorlin syndrome 4
  CYBA       16q24.2         608508   Cytochrome b-245 alpha chain                                       Chronic granulomatous disease, autosomal, due to deficiency of CYBA
  MVD        16q24.2         603236   Mevalonatediphosphate decarboxylase                                Porokeratosis 7, multiple types
  GALNS      16q24.3         612222   Galactosamine (N-acetyl)-6-sulfatase                               Mucopolysaccharidosis IVA
  ACSF3      16q24.3         614245   Acyl-CoA synthetase family member 3                                Combined malonic and methylmalonicaciduria
  CDH15      16q24.3         114019   Cadherin 15                                                        Mental retardation, autosomal dominant 3
  ANKRD11    16q24.3         611192   Ankyrin repeat domain 11                                           KBG syndrome
  SPG7       16q24.3         602783   SPG7, paraplegin matrix AAA peptidase subunit                      Spastic paraplegia 7, autosomal recessive
  CHMP1A     16q24.3         164010   Charged multivesicular body protein 1A                             Pontocerebellar hypoplasia, type 8
  CDK10      16q24.3         603464   Cyclin-dependent kinase 10                                         Al Kaissi syndrome
  FANCA      16q24.3         607139   FA complementation group A                                         Fanconianemia, complementation group A
  MC1R       16q24.3         155555   Melanocortin 1 receptor                                            Albinism, oculocutaneous, type II; Skin/hair/eye pigmentation, variation in, 2; analgesia from kappa-opioid receptor agonist, female-specific; melanoma, cutaneous malignant, 5
  TUBB3      16q24.3         602661   Tubulin beta 3 class III                                           Fibrosis of extraocular muscles, congenital, 3A; cortical dysplasia, complex, with other brain malformations 1
  GAS8       16q24.3         605178   Growth arrest-specific 8                                           Ciliary dyskinesia, primary, 33
  PIEZO1     16q24.3         611184   Piezo type mechanosensitive ion channel component 1                Dehydrated hereditary stomatocytosis with or without pseudohyperkalemia and/or perinatal edema; Lymphatic malformation 6
  APRT       16q24.3         102600   Adenine phosphoribosyltransferase                                  Adenine phosphoribosyltransferase deficiency
